User name
Password

Don't have a user name yet?
Register here.

Help

Lek Launching Protein Modification Facility

MengeŇ°, 23 February - Pharmaceutical company Lek, a subsidiary of Novartis's generics arm Sandoz, will open on Tuesday afternoon a new facility for the production of modified proteins, the Ljubljana-based company announced.

Menges
Lek, a subsidiary of Novartis's generics arm Sandoz, opens a new facility for the production of modified proteins.
Photo: Tamino Petelinsek/STA

Menges
Lek, a subsidiary of Novartis's generics arm Sandoz, opens a new facility for the production of modified proteins.
Photo: Tamino Petelinsek/STA

Menges
Ameet Mallik, the head of biopharmaceuticals department at Sandoz, addressing the opening of a new facility for the production of modified proteins by pharmaceutical company Lek, a subsidiary of Novartis's generics arm Sandoz.
Photo: Tamino Petelinsek/STA

Menges
Health Minister Borut Miklavcic addressing the opening of a new facility for the production of modified proteins by pharmaceutical company Lek, a subsidiary of Novartis's generics arm Sandoz.
Photo: Tamino Petelinsek/STA

The rest of this news item is available to subscribers.
The news item consists of 498 characters (without spaces) or 91 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

zm/eho
© STA, 2010